We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Show more
Ask ADVFN Intelligence (AI)
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa., Dec. 18, 2024 PLYMOUTH MEETING, Pa., Dec. 18, 2024 /PRNewswire/ -- Harmony...
HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT PR Newswire PLYMOUTH MEETING, Pa., Dec. 3, 2024 PLYMOUTH MEETING, Pa., Dec. 3, 2024 /PRNewswire/ -- Harmony...
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES PR Newswire PLYMOUTH MEETING, Pa., Nov. 21, 2024 PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ -- Harmony Biosciences...
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 30, 2024 PLYMOUTH MEETING, Pa., Oct. 30...
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 29, 2024 PLYMOUTH MEETING...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.7822 | 2.26724637681 | 34.5 | 35.2822 | 33.3629 | 340257 | 34.38609711 | CS |
| 4 | 1.5122 | 4.47793899911 | 33.77 | 35.58 | 31.5 | 550672 | 33.7644735 | CS |
| 12 | 0.6622 | 1.9127671866 | 34.62 | 41.61 | 31.02 | 758797 | 34.02630237 | CS |
| 26 | 5.2022 | 17.2945478723 | 30.08 | 41.61 | 29.8 | 580194 | 34.64612997 | CS |
| 52 | 4.7422 | 15.527832351 | 30.54 | 41.61 | 28.14 | 479985 | 33.25597359 | CS |
| 156 | -7.9578 | -18.4037927845 | 43.24 | 62.085 | 18.6112 | 554504 | 38.05123396 | CS |
| 260 | -1.2178 | -3.33643835616 | 36.5 | 62.085 | 18.6112 | 466439 | 37.7254126 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
